Skip to content
Head to head

Trulieve Cannabis vs Takeda Pharmaceutical

Side-by-side on the measures that matter, with a plain-English read. Full detail: TRLV · TAK

Updated 10 minutes ago

1-year performance, rebased to 100

TRLV +66.9%TAK +56.6%
Takeda Pharmaceutical edges it on the scoreable measures. Takeda Pharmaceutical pays the highest dividend yield; Takeda Pharmaceutical earns the most per share.
TRLVTAK
Snapshot
SectorDrug Manufacturers - Specialty & Generic--
Last price8.6821.77
Change today-7.17%+1.68%
1-year return+81.5%+57.5%
Market cap$1.68B$69.76B
52-week range5.00 – 13.2813.92 – 22.07
Valuation
P/E (TTM)-3.76311.00
P/E percentile, own 5-yr range35th100th
P/B2.171.50
Dividend yield0.00%1.44%
Profitability & growth
EPS (TTM)-0.61-0.30
Net profit (TTM)$-117.75M$-970.94M
Revenue (TTM)$1.08B$4.69T
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)-20.1%+6.7%
Gross margin60.6%65.8%
Operating margin12.2%14.3%
Net margin-41.2%0.9%
Free cash flow (TTM)$186.22M$433.95B
Provider cash-flow period date2026-06-292026-09-29
Ownership & sentiment
Institutional ownership28.6%51.3%
Insider activity (12mo)33 buy / 12 sell19 buy / 31 sell
Short interest (% of float)2.0%0.1%
Analyst consensus100% buy (3)100% buy (1)
Analyst price target$18 (+107%)$50 (+132%)
StockVane view
StockVane Quant RatingD (95)C (90)
Company
Employees5,00047,029
Founded19401781

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.